Company / Operating Cash Flow per Share
Tango Therapeutics, Inc. Operating Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.29
FY2025
5-year range
-$1.34 / $1.74
FY2021-FY2025
Trend
-0.2%
vs FY2024
Sector context
#126 of 212
Health Care
What the data says
At $-1.29, Tango Therapeutics, Inc.'s operating cash flow per share ranks #126 of 212 in the Health Care sector. Improved from $-1.34 to $-1.29 over the past 2 years.
Based on SEC 10-K filings.
-1.29 in FY2025.
Improved from $-1.34 to $-1.29 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#126 of 212 in Health CareTop 59% of 212This company -$1.29 Sector average -$14.72
▼
+91.2% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 0.2% year-over-year.
- Ranks #126 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2020.
- Lowest operating cash flow per share in the period was in FY2023.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.29 | -0.2% |
| FY2024 | -$1.29 | +3.8% |
| FY2023 | -$1.34 | -96.6% |
| FY2022 | -$0.68 | -139.2% |
| FY2021 | $1.74 | -20.9% |
| FY2020 | $2.19 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026